| scholarly article | Q13442814 |
| P50 | author | Lorenzo Guglielmetti | Q38642305 |
| Nicolas Veziris | Q42641000 | ||
| Jennifer Hughes | Q57902069 | ||
| P2093 | author name string | J Furin | |
| A Skrahina | |||
| A Shabangu | |||
| C Hewison | |||
| N Kiria | |||
| N Lomtadze | |||
| N Ndjeka | |||
| S Setkina | |||
| W Sikhondze | |||
| Z Avaliani | |||
| P2860 | cites work | Access to new medications for the treatment of drug-resistant tuberculosis: patient, provider and community perspectives | Q28084602 |
| Alarming levels of drug-resistant tuberculosis in Belarus: results of a survey in Minsk. | Q36087053 | ||
| Global Progress and Challenges in Implementing New Medications for Treating Multidrug-Resistant Tuberculosis | Q36617024 | ||
| Factors influencing the effectiveness of interventions to reduce racial and ethnic disparities in health care | Q36725449 | ||
| High prevalence of multidrug-resistant tuberculosis in Georgia | Q37102931 | ||
| New treatment options for multidrug-resistant tuberculosis. | Q38024041 | ||
| Treatment of drug-resistant tuberculosis with bedaquiline in a high HIV prevalence setting: an interim cohort analysis. | Q39297351 | ||
| Compassionate use of bedaquiline for the treatment of multidrug-resistant and extensively drug-resistant tuberculosis: interim analysis of a French cohort | Q41699273 | ||
| Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines | Q42222135 | ||
| A surge of MDR and XDR tuberculosis in France among patients born in the Former Soviet Union. | Q43926052 | ||
| Identification of patients who could benefit from bedaquiline or delamanid: a multisite MDR-TB cohort study. | Q47822279 | ||
| Compassionate and optimum use of new tuberculosis drugs. | Q53813663 | ||
| An intervention programme for the management of multidrug-resistant tuberculosis in France | Q59700709 | ||
| P433 | issue | 2 | |
| P921 | main subject | multidrug-resistant tuberculosis | Q866602 |
| bedaquiline | Q1257318 | ||
| multiple drug resistance | Q643839 | ||
| tuberculosis | Q12204 | ||
| P304 | page(s) | 167-174 | |
| P577 | publication date | 2017-02-01 | |
| P1433 | published in | International Journal of Tuberculosis and Lung Disease | Q15767020 |
| P1476 | title | Examples of bedaquiline introduction for the management of multidrug-resistant tuberculosis in five countries | |
| P478 | volume | 21 |
| Q57026722 | A new era for treatment of drug-resistant tuberculosis |
| Q47244908 | Challenges of using new and repurposed drugs for the treatment of multidrug-resistant tuberculosis in children |
| Q64122518 | Improved treatment outcomes with bedaquiline when substituted for second-line injectable agents in multidrug resistant tuberculosis: a retrospective cohort study |
| Q89635117 | Long-term impact of the adoption of bedaquiline-containing regimens on the burden of drug-resistant tuberculosis in China |
| Q90449409 | Successful implementation of bedaquiline for multidrug-resistant TB treatment in remote Papua New Guinea |
| Q38676708 | The paradigm shift to end tuberculosis. Are we ready to assume the changes? |
| Q92572130 | Tuberculosis |
| Q33627409 | Tuberculosis innovations mean little if they cannot save lives |
Search more.